With Generic Mucinex Delayed, Perrigo Will Need Alternatives To Drive Sales Growth
This article was originally published in The Tan Sheet
Executive Summary
Perrigo hopes to ship store-brand Mucinex expectorant products in time for the next cough and cold season, but analysts are skeptical with several targets for the launch missed already. However, the firm can drive growth through mergers and acquisitions and Rx-to-OTC growth opportunities.